Ibuprofen Market Report 2024 (Global Edition)

Global Ibuprofen Market Report 2024 Market Size Split by Type (Tablet, Capsule, Syrup, Injection, Others), by Application (Rheumatoid Arthritis and Osteoarthritis, Cancer, Pain/Fever/Dysmenorrhea, Inf...

Ibuprofen Market Report Description

We have various report editions of Ibuprofen Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Ibuprofen Market

The ibuprofen market showcases fierce competition, with major players continually innovating to maintain market share and expand into emerging regions. Regulatory scrutiny on safety and efficacy adds another layer of challenge, prompting companies to invest in rigorous testing and compliance measures to ensure product quality and consumer trust.

November 2022: Solara Active Pharma Sciences Limited's new cutting-edge, multipurpose API manufacturing facility in Vishakhapatnam, Andhra Pradesh, received Certificate of Suitability (CEP) approval for manufacturing ibuprofen API from the European Directorate for the Quality of Medicine (EDQM). (Source:https://www.business-standard.com/article/news-cm/solara-receives-edqm-cep-approval-for-its-api-unit-in-vishakhapatnam-122110100333_1.html)

Top Companies Market Share in Ibuprofen Industry: (In no particular order of Rank)

• Lonza
• BIOCAUSE Inc.
• IOL Chemicals and Pharmaceuticals Limited
• Granules India Limited
• SALVAVIDAS PHARMACEUTICAL PVT. LTD.
• Anantco Enterprises Pvt. Ltd.
• Sri Krishna Pharmaceuticals Ltd.
• Taj Pharmaceuticals Limited
• Wellona Pharma
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Ibuprofen Market

Which Region Dominates the Ibuprofen Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue due to the region's increasing incidences of pain-related ailments, rising consumer awareness regarding self-medication, well-established healthcare infrastructure, and widespread availability of over-the-counter medications. Additionally, strategic initiatives by key market players, including product innovations and marketing campaigns, bolster market penetration. Moreover, favorable government regulations regarding pharmaceuticals also facilitate market growth in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the ibuprofen market due to the region's increasing healthcare expenditure, rising geriatric population, and growing awareness about the benefits of ibuprofen for pain relief and anti-inflammatory purposes. Countries are witnessing significant demand due to the large population base and increasing prevalence of chronic diseases. Moreover, the expanding pharmaceutical industry and favorable government initiatives toward healthcare infrastructure development further contribute to market expansion in the region.

The current report Scope analyzes Ibuprofen Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Ibuprofen

According to Cognitive Market Research, the global ibuprofen market size was estimated at USD 121.6 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 48.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031

• According to Cognitive Market Research, the US had a major share in the hydraulic turbines market with a market size of USD 365.62 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. The nation's stringent government regulations amplify the demand.
• The Canadian hydraulic turbines market had a market share of USD 55.61 million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. Canada's continuous technological improvements.
• The Mexico hydraulic turbines market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 42.17 million in 2024.

coupled with the high consumption of analgesics, propels the demand for ibuprofen in the region.

• According to Cognitive Market Research, the US had a major share in the ibuprofen market with a market size of USD 38.38 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. The nation's increasing awareness of self-medication amplifies the demand.
• The Canada ibuprofen market had a market share of USD 5.84 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Canada's growing preference for over-the-counter (OTC) pain relief options propels the demand.
• The Mexico ibuprofen market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 4.43 million in 2024.

Europe Ibuprofen

According to Cognitive Market Research, the global ibuprofen market size was estimated at USD 121.6 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 36.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• The United Kingdom ibuprofen market had a market share of USD 6.13 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. In the UK, ibuprofen sales witness an upswing due to the nation's higher prevalence of conditions such as arthritis and other musculoskeletal disorders.
• The France ibuprofen market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 3.36 million in 2024.
• According to Cognitive Market Research, the German ibuprofen market size was valued at USD 7.22 million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period. In Germany, ibuprofen surged due to the convenience of obtaining ibuprofen without a prescription.
• The Italy ibuprofen market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 3.14 million in 2024.
• The Russia ibuprofen market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 5.65 million in 2024.
• The Spain ibuprofen market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 2.99 million in 2024
• The Luxembourg ibuprofen market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 1.13 million in 2024.
• The Portugal ibuprofen market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 0.77 million in 2024.
• The Greece ibuprofen market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 0.44 million in 2024.
• Rest of Europe's ibuprofen market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 5.65 million in 2024.

Asia Pacific Ibuprofen

According to Cognitive Market Research, the global ibuprofen market size was estimated at USD 121.6 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 27.97 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.

• According to Cognitive Market Research, China's ibuprofen market size was valued at USD 12.59 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period. Ibuprofen has surged in China due to the expansion of healthcare infrastructure and rising health awareness.
• The Japan ibuprofen market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 3.86 million in 2024.
• The India ibuprofen market had a market share of USD 3.36 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. India's surge in online retailing and e-pharmacy platforms propels the demand.
• The South Korean ibuprofen market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 2.80 million in 2024.
• The Australian ibuprofen market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 1.45 million in 2024.
• The South East Asia ibuprofen market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 1.93 million in 2024.
• The Rest of Asia Pacific ibuprofen market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 1.99 million in 2024.

South America Ibuprofen

According to Cognitive Market Research, the global ibuprofen market size was estimated at USD 121.6 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 6.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

• According to Cognitive Market Research, Brazil's ibuprofen market size was valued at USD 2.60 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Ibuprofen flourish in Brazil due to the increasing healthcare expenditure.
• Argentina's ibuprofen market had a market share of USD 1.02 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Argentina's expanding middle-class population augments the demand.
• Colombia's ibuprofen market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 0.54 million in 2024.
• Peru's ibuprofen market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 0.50 million in 2024.
• Chile ibuprofen market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 0.44 million in 2024.
• The Rest of Latin America ibuprofen market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 0.98 million in 2024.

Middle East and Africa Ibuprofen

According to Cognitive Market Research, the global ibuprofen market size was estimated at USD 121.6 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 2.43 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

• The GCC Countries ibuprofen market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 1.04 million in 2024. Ibuprofen sales flourish due to the high incidence of lifestyle-related diseases.
• The Egypt ibuprofen market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 0.26 million in 2024.
• The South Africa ibuprofen market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 0.38 million in 2024. Ibuprofen sales flourish in South Africa due to the expansion of the pharmaceutical sector.
• The Turkey ibuprofen market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 0.21 million in 2024.
• The Nigeria ibuprofen market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 0.26 million in 2024.
• The Rest of MEA ibuprofen market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 0.29 million in 2024.

Ibuprofen Market Analysis

How are Segments Performing in the Global Ibuprofen Market?

Ibuprofen Market Type Segment Analysis

According to Cognitive Market Research, tablets stand out as the dominating category. They are widely used due to their ease of administration, accurate dosing, and cost-effectiveness. They are favored in both prescription and over-the-counter markets.

Capsule emerge as the fastest-growing category in the ibuprofen market. They offer benefits such as faster dissolution and absorption, which can lead to quicker relief of symptoms. They are especially popular among individuals who prefer easier swallowing and those needing rapid symptom alleviation.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Ibuprofen Industry. Request a Free Sample PDF!

According to Cognitive Market Research, the dominating category in the ibuprofen market is rheumatoid arthritis and osteoarthritis. Ibuprofen serves as a nonsteroidal anti-inflammatory drug (NSAID) to reduce inflammation, pain, and swelling, improving patient mobility and quality of life.

The fastest-growing category in the ibuprofen market is cancer. Ibuprofen is used to alleviate pain and inflammation associated with tumors or treatment side effects, providing significant palliative relief.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion